vs

Side-by-side financial comparison of CME Group (CME) and CARLISLE COMPANIES INC (CSL). Click either name above to swap in a different company.

CME Group is the larger business by last-quarter revenue ($1.9B vs $1.1B, roughly 1.8× CARLISLE COMPANIES INC). CARLISLE COMPANIES INC runs the higher net margin — 12.1% vs 0.1%, a 12.1% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs -4.0%). Over the past eight quarters, CME Group's revenue compounded faster (10.8% CAGR vs -14.8%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

Carlisle Companies Incorporated is a supplier of construction products that make buildings more energy efficient and resilient. The company manufactures and sells single-ply roofing products as well as warranted systems and accessories for the commercial building industry. The company is organized into two segments, including Carlisle Construction Materials and Carlisle Weatherproofing Technologies. The company's product portfolio includes moisture protection products, protective roofing unde...

CME vs CSL — Head-to-Head

Bigger by revenue
CME
CME
1.8× larger
CME
$1.9B
$1.1B
CSL
Growing faster (revenue YoY)
CME
CME
+18.5% gap
CME
14.5%
-4.0%
CSL
Higher net margin
CSL
CSL
12.1% more per $
CSL
12.1%
0.1%
CME
Faster 2-yr revenue CAGR
CME
CME
Annualised
CME
10.8%
-14.8%
CSL

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CME
CME
CSL
CSL
Revenue
$1.9B
$1.1B
Net Profit
$1.2M
$127.7M
Gross Margin
34.5%
Operating Margin
0.1%
17.1%
Net Margin
0.1%
12.1%
Revenue YoY
14.5%
-4.0%
Net Profit YoY
20.7%
-10.9%
EPS (diluted)
$3.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
CSL
CSL
Q1 26
$1.9B
$1.1B
Q4 25
$1.6B
$1.1B
Q3 25
$1.5B
$1.3B
Q2 25
$1.7B
$1.4B
Q1 25
$1.6B
$1.1B
Q4 24
$1.5B
$1.1B
Q3 24
$1.6B
$1.3B
Q2 24
$1.5B
$1.5B
Net Profit
CME
CME
CSL
CSL
Q1 26
$1.2M
$127.7M
Q4 25
$1.2B
$127.4M
Q3 25
$908.0M
$214.2M
Q2 25
$1.0B
$255.8M
Q1 25
$956.2M
$143.3M
Q4 24
$874.6M
$162.8M
Q3 24
$912.8M
$244.3M
Q2 24
$883.2M
$712.4M
Gross Margin
CME
CME
CSL
CSL
Q1 26
34.5%
Q4 25
33.8%
Q3 25
36.0%
Q2 25
37.3%
Q1 25
35.2%
Q4 24
36.1%
Q3 24
38.6%
Q2 24
39.2%
Operating Margin
CME
CME
CSL
CSL
Q1 26
0.1%
17.1%
Q4 25
61.8%
16.8%
Q3 25
63.3%
21.8%
Q2 25
66.7%
23.1%
Q1 25
67.5%
16.8%
Q4 24
62.1%
19.9%
Q3 24
64.6%
23.7%
Q2 24
65.3%
26.0%
Net Margin
CME
CME
CSL
CSL
Q1 26
0.1%
12.1%
Q4 25
71.7%
11.3%
Q3 25
59.1%
15.9%
Q2 25
60.6%
17.6%
Q1 25
58.2%
13.1%
Q4 24
57.3%
14.5%
Q3 24
57.6%
18.3%
Q2 24
57.6%
49.1%
EPS (diluted)
CME
CME
CSL
CSL
Q1 26
$3.10
Q4 25
$3.24
$3.06
Q3 25
$2.49
$4.98
Q2 25
$2.81
$5.88
Q1 25
$2.62
$3.20
Q4 24
$2.40
$3.76
Q3 24
$2.50
$5.25
Q2 24
$2.42
$14.84

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
CSL
CSL
Cash + ST InvestmentsLiquidity on hand
$2.4B
$771.3M
Total DebtLower is stronger
$3.4B
Stockholders' EquityBook value
$1.7B
Total Assets
$202.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
CSL
CSL
Q1 26
$2.4B
$771.3M
Q4 25
$4.5B
$1.1B
Q3 25
$2.6B
$1.1B
Q2 25
$2.1B
$68.4M
Q1 25
$1.5B
$220.2M
Q4 24
$3.0B
$753.5M
Q3 24
$2.4B
$1.5B
Q2 24
$1.9B
$1.7B
Total Debt
CME
CME
CSL
CSL
Q1 26
$3.4B
Q4 25
$2.9B
Q3 25
$2.9B
Q2 25
$1.9B
Q1 25
$1.9B
Q4 24
$1.9B
Q3 24
$2.3B
Q2 24
$2.3B
Stockholders' Equity
CME
CME
CSL
CSL
Q1 26
$1.7B
Q4 25
$28.7B
$1.8B
Q3 25
$28.2B
$2.0B
Q2 25
$27.7B
$2.1B
Q1 25
$27.0B
$2.2B
Q4 24
$26.5B
$2.5B
Q3 24
$28.2B
$2.8B
Q2 24
$27.6B
$3.0B
Total Assets
CME
CME
CSL
CSL
Q1 26
$202.0B
Q4 25
$198.4B
$6.3B
Q3 25
$187.1B
$6.5B
Q2 25
$179.9B
$5.5B
Q1 25
$157.8B
$5.5B
Q4 24
$137.4B
$5.8B
Q3 24
$137.8B
$6.5B
Q2 24
$123.4B
$6.7B
Debt / Equity
CME
CME
CSL
CSL
Q1 26
Q4 25
1.61×
Q3 25
1.45×
Q2 25
0.89×
Q1 25
0.87×
Q4 24
0.77×
Q3 24
0.83×
Q2 24
0.76×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
CSL
CSL
Operating Cash FlowLast quarter
Free Cash FlowOCF − Capex
$-73.0M
FCF MarginFCF / Revenue
-6.9%
Capex IntensityCapex / Revenue
2.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$924.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
CSL
CSL
Q1 26
Q4 25
$1.1B
$386.0M
Q3 25
$968.1M
$426.9M
Q2 25
$1.1B
$287.1M
Q1 25
$1.1B
$1.8M
Q4 24
$1.0B
$370.6M
Q3 24
$1.0B
$312.8M
Q2 24
$776.9M
$183.4M
Free Cash Flow
CME
CME
CSL
CSL
Q1 26
$-73.0M
Q4 25
$1.1B
$346.1M
Q3 25
$949.7M
$393.4M
Q2 25
$1.0B
$258.3M
Q1 25
$1.1B
$-27.2M
Q4 24
$991.7M
$334.0M
Q3 24
$973.2M
$293.5M
Q2 24
$758.7M
$158.5M
FCF Margin
CME
CME
CSL
CSL
Q1 26
-6.9%
Q4 25
66.8%
30.7%
Q3 25
61.8%
29.2%
Q2 25
61.5%
17.8%
Q1 25
67.1%
-2.5%
Q4 24
65.0%
29.7%
Q3 24
61.4%
22.0%
Q2 24
49.5%
10.9%
Capex Intensity
CME
CME
CSL
CSL
Q1 26
2.7%
Q4 25
2.0%
3.5%
Q3 25
1.2%
2.5%
Q2 25
1.1%
2.0%
Q1 25
0.9%
2.6%
Q4 24
1.7%
3.3%
Q3 24
1.9%
1.4%
Q2 24
1.2%
1.7%
Cash Conversion
CME
CME
CSL
CSL
Q1 26
Q4 25
0.96×
3.03×
Q3 25
1.07×
1.99×
Q2 25
1.03×
1.12×
Q1 25
1.17×
0.01×
Q4 24
1.16×
2.28×
Q3 24
1.10×
1.28×
Q2 24
0.88×
0.26×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CME
CME

Segment breakdown not available.

CSL
CSL

CCM$758.0M72%
CWT$294.0M28%

Related Comparisons